Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)

Summary

The PROCTO trial is a double-blind randomized, placebo-controlled, 24-week, comparative, exploratory phase II proof of concept trial. The trial will be conducted with 2 treatment groups as a parallel group comparison and will serve to compare a 7500 TSO regimen vs. placebo for achieving clinically meaningful responses in Ulcerative Colitis.

Timeline

Start

2018-05-04

Primary completion

2022-01-10

Completion

2022-01-10

Drugs

Indications